These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2632409)

  • 41. Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.
    Brus R; Krzemiński T; Piguła J
    Pol J Pharmacol Pharm; 1983; 35(5):377-82. PubMed ID: 6686676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of opiates and endogenous opioid peptides in the regulation of rat TSH secretion.
    Sharp B; Morley JE; Carlson HE; Gordon J; Briggs J; Melmed S; Hershman JM
    Brain Res; 1981 Aug; 219(2):335-44. PubMed ID: 6266605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
    Flores CM; Hulihan-Giblin BA; Hornby PJ; Lumpkin MD; Kellar KJ
    Neuroendocrinology; 1992 May; 55(5):519-28. PubMed ID: 1350068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid and non-opioid central cardiovascular effects of ketamine.
    Seth S; Mukherjee D; Choudhary AK; Sinha JN; Gurtu S
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):535-8. PubMed ID: 1965327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the mechanisms of the development of tolerance to the muscular rigidity produced by morphine in rats.
    Themann P; Havemann U; Kuschinsky K
    Eur J Pharmacol; 1986 Oct; 129(3):315-21. PubMed ID: 3780846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of naloxone on pressor responses to angiotensin II in anaesthetized greyhounds.
    Wilkinson DL; Scroop GC
    Clin Exp Pharmacol Physiol; 1986 Mar; 13(3):179-86. PubMed ID: 3720019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opiate-androgen interactions in drug-induced yawning and penile erections in the rat.
    Berendsen HH; Gower AJ
    Neuroendocrinology; 1986; 42(3):185-90. PubMed ID: 3951672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.
    Kondo Y; Iwatsubo K
    Brain Res; 1980 Jan; 181(1):237-40. PubMed ID: 7350960
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of morphine and neuroleptics on wet-dog shaking behavior elicited by hippocampal stimulation in rats.
    Araki H; Aihara H
    Psychopharmacology (Berl); 1985; 85(3):301-5. PubMed ID: 2860686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of dopaminergic receptor signaling in the effects of glutamatergic receptor antagonists on conditioned place aversion induced by naloxone in single-dose morphine-treated rats.
    Kawasaki Y; Araki H; Suemaru K; Kitamura Y; Gomita Y; Sendo T
    J Pharmacol Sci; 2011; 117(1):27-33. PubMed ID: 21821972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
    Arenas E; Alberch J; Marsal J
    Neuroscience; 1991; 42(3):707-14. PubMed ID: 1683474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blockade of the dopamine depressor response by molindone, a newly introduced neuroleptic.
    Nandal NV; Mane VR; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(2):143-7. PubMed ID: 6103868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Demonstration of intrathecal and systemic morphine and ST-91 effects on fed canine upper gut motility.
    Thomforde GM; Malagelada JR; Camilleri M; Yaksh TL
    Dig Dis Sci; 1990 Oct; 35(10):1249-56. PubMed ID: 1976496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender differences in the cardiovascular responses to morphine and naloxone in spinal rats.
    Cruz SL; Rodríguez-Manzo G
    Eur J Pharmacol; 2000 May; 397(1):121-8. PubMed ID: 10844106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Naloxazone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine.
    Holaday JW; Pasternak GW; Faden AI
    Neurosci Lett; 1983 Jun; 37(2):199-204. PubMed ID: 6308526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central opiate system modulation of the area postrema pressor pathway.
    Szilagyi JE; Ferrario CM
    Hypertension; 1981; 3(3):313-7. PubMed ID: 7251091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Naloxone blockade of morphine analgesia: a dose-effect study of duration and magnitude.
    Markowitz R; Jacobson J; Bain G; Kornetsky C
    J Pharmacol Exp Ther; 1976 Nov; 199(2):385-8. PubMed ID: 978492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of haloperidol pretreatment on the morphine toxicity.
    Andreas K; Fischer HD; Rudolph E; Brösgen G
    Arch Toxicol Suppl; 1980; 4():471-4. PubMed ID: 6933966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.
    Paquette NC; Young GA
    Eur J Pharmacol; 1991 Apr; 196(1):61-7. PubMed ID: 1678713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.